| |
| |
|
| Insider
Information: |
Patrick Gregory S |
| Relationship: |
Sr. VP Chief Financial... |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
44,463 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,370,794 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,463 |
|
|
| Total
Value |
$1,370,794 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Supernus Pharmaceuticals Inc |
SUPN |
Sr. VP Chief Financial... |
2020-11-09 |
44,463 |
2012-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP Chief Financial Officer |
• – – |
2020-11-09 |
4 |
AS |
$25.00 |
$125,000 |
D/D |
(5,000) |
44,463 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP Chief Financial Officer |
• – – |
2020-11-09 |
4 |
OE |
$12.98 |
$64,900 |
D/D |
5,000 |
49,463 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP, CFO |
• – – |
2020-11-05 |
4 |
AS |
$23.00 |
$115,000 |
D/D |
(5,000) |
44,463 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP, CFO |
• – – |
2020-11-05 |
4 |
OE |
$12.98 |
$64,900 |
D/D |
5,000 |
49,463 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP, CFO |
• – – |
2020-10-15 |
4 |
AS |
$20.03 |
$300,507 |
D/D |
(15,000) |
44,463 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP, CFO |
• – – |
2020-10-15 |
4 |
OE |
$12.98 |
$194,700 |
D/D |
15,000 |
59,463 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr.VP, Chief Financial Officer |
• – – |
2020-08-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,120 |
44,463 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr.VP, Chief Financial Officer |
• – – |
2020-08-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
45,583 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr.VP, Chief Financial Officer |
• – – |
2020-05-20 |
4 |
AS |
$25.03 |
$375,380 |
D/D |
(15,000) |
46,057 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr.VP, Chief Financial Officer |
• – – |
2020-05-20 |
4 |
OE |
$12.98 |
$194,700 |
D/D |
15,000 |
61,057 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr VP, Chief Financial Officer |
• – – |
2020-05-08 |
4 |
AS |
$23.14 |
$347,034 |
D/D |
(15,000) |
46,057 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr VP, Chief Financial Officer |
• – – |
2020-05-08 |
4 |
OE |
$9.13 |
$136,950 |
D/D |
15,000 |
61,057 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP,Chief Financial Officer |
• – – |
2019-07-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,590 |
45,682 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr VP, Chief Financial Officer |
• – – |
2019-02-27 |
4 |
AS |
$41.53 |
$830,650 |
D/D |
(20,000) |
47,896 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr VP, Chief Financial Officer |
• – – |
2019-02-27 |
4 |
OE |
$9.13 |
$182,600 |
D/D |
20,000 |
67,896 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2018-07-02 |
4 |
AS |
$56.63 |
$1,981,914 |
D/D |
(35,000) |
55,975 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2018-07-02 |
4 |
OE |
$9.13 |
$321,750 |
D/D |
35,000 |
90,975 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2018-01-11 |
4 |
AS |
$43.56 |
$2,178,145 |
D/D |
(50,000) |
55,975 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2018-01-11 |
4 |
OE |
$5.88 |
$582,200 |
D/D |
75,000 |
105,975 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2017-09-08 |
4 |
OE |
$5.88 |
$273,700 |
D/D |
38,481 |
30,716 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2017-09-08 |
4 |
AS |
$48.89 |
$1,147,965 |
D/D |
(23,481) |
15,716 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2017-09-07 |
4 |
AS |
$46.36 |
$1,231,815 |
D/D |
(26,519) |
716 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2017-09-07 |
4 |
OE |
$5.88 |
$297,700 |
D/D |
41,519 |
15,716 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2017-04-24 |
4 |
AS |
$32.37 |
$1,747,872 |
D/D |
(54,000) |
221 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
VP, Chief Financial Officer |
• – – |
2017-04-24 |
4 |
OE |
$5.88 |
$294,000 |
D/D |
50,000 |
54,221 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
